Background: Cryptococcosis is a global invasive mycosis associated with significant morbidity and mortality. Cryptococcal antigen (CrAg) testing from serum and cerebrospinal fluid (CSF) has been regarded as a gold standard for early diagnosis. This study aimed to develop and validate a rapid and sensitive sandwich chemiluminescent magnetic microparticle immunoassay (CMIA) for quantitative detection of CrAg in sera.
Research Design And Methods: CMIA is based on magnetic beads modified with capture antibodies and biotinylated antibodies and Streptavidin-polyHRP, where biotinylated antibodies functioned as the recognition element and Streptavidin-polyHRP as the signal component. Assay parameters were first optimized, and then assay performances were evaluated.
Results: Under optimized conditions, the total runtime of the CMIA was 22 min. The assay had a wide linear range (2 -10,000 ng/mL) and high analytical sensitivity (0.24 ng/mL), together with acceptable reproducibility, accuracy, and stability. Besides, it exhibited no cross-reactivity with other pathogens. Importantly, the assay showed 92.91% (95% CI, 80.97-93.02%) overall qualitative agreement with a commercial ELISA kit in a retrospective cohort of 55 cases with confirmed cryptococcal infection, and 72 controls without evidence of invasive fungal disease (IFD).
Conclusion: These results demonstrated that the present study paved a novel strategy for reliable quantitative detection of CrAg in sera.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14737159.2024.2369243 | DOI Listing |
Spectrochim Acta A Mol Biomol Spectrosc
January 2025
Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, PR China; School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, PR China.
J Family Med Prim Care
November 2024
Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
Introduction: Intravenous iron sucrose (IVIS) is a rapidly acting, safe, and effective treatment for moderate anemia among pregnant women. The effectiveness of IVIS at 6 months post IVIS infusion was unknown. We, therefore, assessed the mean increase in hemoglobin concentration and body iron replenishment status at 6 months after the last dose of IVIS infusion.
View Article and Find Full Text PDFHeliyon
December 2024
Department of Immunology, The Fourth Military Medical University, Xi'an, China.
Food Chem
March 2025
College of Life Science, Yangtze University, Jingzhou 434023, Hubei Province, PR China.
This work aimed to develop a fluorescence/colorimetric sensor for the ultrasensitive detection of AFB1 based on the aptamers and molecular imprinted polymers (MIPs). The polydopamine on FeO (FeO@MIP) was used to achieve efficient separation of AFB1. The aptamer-modified carbon dots and metal-organic frameworks (Apt-CDs@MOF) were used to form sandwich particles (FeO@MIP-AFB1-Apt-CDs@MOF).
View Article and Find Full Text PDFACS Appl Mater Interfaces
November 2024
Key Laboratory of Synthetic and Natural Functional Molecule of Ministry of Education, College of Chemistry & Materials Science, Northwest University, Xi'an, 710127, Shaanxi People's Republic of China.
Introducing novel catalysts is essential for developing chemiluminescence (CL) systems that exhibit sustained and robust emission. Traditional Luminol-HO systems typically feature flash-type CL emission. In this study, we discovered that the porous material HKUST-1 can induce a long-lasting and intense CL emission when combined with Luminol-HO.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!